Nasdaq
Alvotech’s Financial Calendar for 2026
22-12-2025
Alvotech (NASDAQ: ALVO, ALVO SDB) today publishes its financial calendar for 2026. Annual or interim results are released on the dates specified below, after the close of U.S. markets. An investor call is held on the following day, after release of the results.
March 18, 2026: Q4 2025 – full-year 2025
May 6, 2026: Q1 2026
August 19, 2026: Q2 2026 – first six months
November 11, 2026: Q3 2026 – first nine months
March 10, 2027: Q4 2026 – full-year 2026
June 3, 2026: Annual General Meeting (held in Luxembourg)
Please note that all dates are subject to change.
Alvotech Investor Relations
Balaji Prasad (US)
Benedikt Stefánsson, VP (IS)
Patrik Ling, VP (SE)
alvotech.ir@alvotech.com
Latest Health & Supplement Reviews
- Neuro Energizer Reviews and Complaints 2026: How This Neuro-Sonic Breakthrough Is Reshaping Cognitive Therapy, Memory & Daily Focus
- Gluco6 Reviews and Complaints (March 2026) Real User Data on Natural Blood Sugar Balance and Glucose Stability
- Prime Biome Reviews (March 2026 Report) Doctor Explains Gut Skin Microbiome Reset And New Discoveries